Cancer Therapy Due to Apoptosis: Galectin-9
Dysregulation of apoptosis is a major hallmark in cancer biology that might equip tumors with a higher malignant potential and chemoresistance. The anti-cancer activities of lectin, defined as a carbohydrate-binding protein that is not an enzyme or antibody, have been investigated for over a century...
Main Authors: | Koji Fujita, Hisakazu Iwama, Kyoko Oura, Tomoko Tadokoro, Eri Samukawa, Teppei Sakamoto, Takako Nomura, Joji Tani, Hirohito Yoneyama, Asahiro Morishita, Takashi Himoto, Mitsuomi Hirashima, Tsutomu Masaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/1/74 |
Similar Items
-
Galectin-9 in Gastroenterological Cancer
by: Asahiro Morishita, et al.
Published: (2023-03-01) -
In vitro evaluation of the effect of galectins on Schistosoma mansoni motility
by: Tomoharu Takeuchi, et al.
Published: (2023-10-01) -
A brief history of galectin evolution
by: Juliane Günther, et al.
Published: (2023-06-01) -
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
by: Guillermo A. Videla-Richardson, et al.
Published: (2021-12-01) -
Role of Galectins in Multiple Myeloma
by: Paola Storti, et al.
Published: (2017-12-01)